The skin biopsy market valued for $101.20 million in 2021 and is estimated to reach $181.58 million by 2031, exhibiting a CAGR of 6.0% from 2022 to 2031.
Skin biopsy may be defined as one of the easy and safest diagnostic technique used in diagnosis of skin related conditions in humans. Skin biopsy technique involves the removal of small skin patch or skin lesion and later observing it under the microscope. The procedure is usually carried out in the clinic or in physician's office, and gives diagnostic results in 4 to 10 days. Skin biopsy is used for the detection of diseases such as skin cancer, infection, or other skin disorders. Skin biopsies are of different types such as shave biopsy, punch biopsy, and excisional biopsy. Skin sample is collected through one of the above-mentioned techniques and then examined under a microscope to determine the presence of any disease.
Furthermore, skin biopsy is indicated in case of various skin disorders such as skin cancer, actinic keratosis, dermatitis, psoriasis, skin infection and others. Moreover, skin biopsy can also be used in conditions such as blistering skin disorders, actinic keratosis presents as rough and scaly patches on the skin of older adults, skin tags, warts, inflammatory skin disorders, occasional skin infections, systemic diseases that have skin or soft tissue manifestation for diagnosis process. Thus, such wide applications of skin biopsy in diagnosis of skin disorders, propels its demand in the healthcare industry. This, in turn, propels the growth of the skin biopsy market. The major factor driving the growth of skin biopsy market includes the increase in incidences of skin cancer in developed and developing regions. There is a rise in skin cancer cases around the globe, and majorly in the developed countries.
Also, in the past decade, malignant melanoma (MM) and keratinocyte carcinoma (KC) incidences are increasing rapidly around the globe. This increase in skin cancer cases is mainly attributed to the changing lifestyle of the population in developed regions along with some environmental factors such as ultraviolet (UV) exposure, & radiation exposure and genetics & immunosuppression. For instance, according to the AIM at Melanoma foundation, in 2022, an estimated 197,700 cases of melanoma were diagnosed in the U.S. Of those, 97,920 cases were in situ (noninvasive), confined to the top layer of skin, and 99,780 cases was invasive, penetrating the epidermis into the skin’s second layer. Moreover, among the invasive cases, 57,180 were men and 42,600 were women. Thus, such huge incidences of skin cancer in 2022 and coming years, is anticipated to drive the growth of skin biopsy market.
In addition, major key players are offering wide range of skin biopsy products with significant product differentiation. For instance, the Innnovia Medicals (DTR Medical Ltd.) offers various readily available single-use instruments kits for skin biopsy, such as SBIG1004, SBIG1005, SBIG1007 and SBIG1307, which includes Iris Scissors Straight 110mm, No3 Blade Handle, Baby Metzenbaum Scissors 120mm, Adson Dissecting Forceps Toothed 120mm, Mosquito Forceps Straight 125mm, Halsey Needle Holder 130mm, Gillies Skin Hook Sharp 175mm and other instruments. Thus, increase in such product offering by the key market players is anticipated to increase the adoption of skin biopsy technique by healthcare providers and patients and thereby augment the growth of the market. Although, various key factors are driving the growth of the market, there are few factors such as high cost of the procedures and devices is providing hindrance to the growth of the market. These high prices create limitations in accessing skin biopsy techniques majorly in developing and underdeveloped countries. Also, availability of new alternatives for skin biopsy and lack of awareness about advanced diagnostic procedures for skin disorders, also acts as a restraint to the growth of the market.
The skin biopsy market is segmented into type, indication, end user and region. By type, the market is categorized into shave biopsy, punch biopsy, and excisional biopsy. By indication, the market is segregated into skin cancer, actinic keratosis, dermatitis, and others. By end user, the market is categorized into hospitals and clinics, diagnostic laboratories and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global skin biopsy market are AccuTec, Inc., Becton, Dickinson and Company, Cardinal Health, Innovia Medical (DTR Medical Ltd), Integra LifeSciences, Jai Surgicals Ltd., Kai Group, Paramount Surgimed Ltd., Verna care and World Precision Instruments (WPI).
Skin biopsy may be defined as one of the easy and safest diagnostic technique used in diagnosis of skin related conditions in humans. Skin biopsy technique involves the removal of small skin patch or skin lesion and later observing it under the microscope. The procedure is usually carried out in the clinic or in physician's office, and gives diagnostic results in 4 to 10 days. Skin biopsy is used for the detection of diseases such as skin cancer, infection, or other skin disorders. Skin biopsies are of different types such as shave biopsy, punch biopsy, and excisional biopsy. Skin sample is collected through one of the above-mentioned techniques and then examined under a microscope to determine the presence of any disease.
Furthermore, skin biopsy is indicated in case of various skin disorders such as skin cancer, actinic keratosis, dermatitis, psoriasis, skin infection and others. Moreover, skin biopsy can also be used in conditions such as blistering skin disorders, actinic keratosis presents as rough and scaly patches on the skin of older adults, skin tags, warts, inflammatory skin disorders, occasional skin infections, systemic diseases that have skin or soft tissue manifestation for diagnosis process. Thus, such wide applications of skin biopsy in diagnosis of skin disorders, propels its demand in the healthcare industry. This, in turn, propels the growth of the skin biopsy market. The major factor driving the growth of skin biopsy market includes the increase in incidences of skin cancer in developed and developing regions. There is a rise in skin cancer cases around the globe, and majorly in the developed countries.
Also, in the past decade, malignant melanoma (MM) and keratinocyte carcinoma (KC) incidences are increasing rapidly around the globe. This increase in skin cancer cases is mainly attributed to the changing lifestyle of the population in developed regions along with some environmental factors such as ultraviolet (UV) exposure, & radiation exposure and genetics & immunosuppression. For instance, according to the AIM at Melanoma foundation, in 2022, an estimated 197,700 cases of melanoma were diagnosed in the U.S. Of those, 97,920 cases were in situ (noninvasive), confined to the top layer of skin, and 99,780 cases was invasive, penetrating the epidermis into the skin’s second layer. Moreover, among the invasive cases, 57,180 were men and 42,600 were women. Thus, such huge incidences of skin cancer in 2022 and coming years, is anticipated to drive the growth of skin biopsy market.
In addition, major key players are offering wide range of skin biopsy products with significant product differentiation. For instance, the Innnovia Medicals (DTR Medical Ltd.) offers various readily available single-use instruments kits for skin biopsy, such as SBIG1004, SBIG1005, SBIG1007 and SBIG1307, which includes Iris Scissors Straight 110mm, No3 Blade Handle, Baby Metzenbaum Scissors 120mm, Adson Dissecting Forceps Toothed 120mm, Mosquito Forceps Straight 125mm, Halsey Needle Holder 130mm, Gillies Skin Hook Sharp 175mm and other instruments. Thus, increase in such product offering by the key market players is anticipated to increase the adoption of skin biopsy technique by healthcare providers and patients and thereby augment the growth of the market. Although, various key factors are driving the growth of the market, there are few factors such as high cost of the procedures and devices is providing hindrance to the growth of the market. These high prices create limitations in accessing skin biopsy techniques majorly in developing and underdeveloped countries. Also, availability of new alternatives for skin biopsy and lack of awareness about advanced diagnostic procedures for skin disorders, also acts as a restraint to the growth of the market.
The skin biopsy market is segmented into type, indication, end user and region. By type, the market is categorized into shave biopsy, punch biopsy, and excisional biopsy. By indication, the market is segregated into skin cancer, actinic keratosis, dermatitis, and others. By end user, the market is categorized into hospitals and clinics, diagnostic laboratories and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global skin biopsy market are AccuTec, Inc., Becton, Dickinson and Company, Cardinal Health, Innovia Medical (DTR Medical Ltd), Integra LifeSciences, Jai Surgicals Ltd., Kai Group, Paramount Surgimed Ltd., Verna care and World Precision Instruments (WPI).
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the skin biopsy market analysis from 2021 to 2031 to identify the prevailing skin biopsy market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the skin biopsy market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global skin biopsy market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Type- Shave Biopsy
- Punch Biopsy
- Excisional Biopsy
- Skin cancer
- Actinic keratosis
- Dermatitis
By End User
- Hospital and Clinics
- Diagnostic Laboratories
- Other
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- AccuTec, Inc.
- Cardinal Health Inc.
- Innovia Medical
- Jai Surgicals Ltd.
- Integra LifeSciences
- Vernacare
- Becton, Dickinson and Company
- KAI Group
- Paramount Surgimed Limited
- World Precision Instruments
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of skin cancer
3.4.1.2. Increase in incidences of skin disorders
3.4.1.3. Rise in adoption of minimally invasive procedures
3.4.2. Restraints
3.4.2.1. High cost of skin biopsy procedures
3.4.2.2. Presence of new alternatives to skin biopsies
3.4.3. Opportunities
3.4.3.1. Growth opportunity in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: SKIN BIOPSY MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Shave Biopsy
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Punch Biopsy
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Excisional Biopsy
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: SKIN BIOPSY MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Skin cancer
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Actinic keratosis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Dermatitis
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: SKIN BIOPSY MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital and Clinics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Diagnostic Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Other
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: SKIN BIOPSY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Indication
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Indication
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Indication
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Indication
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Indication
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Indication
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Indication
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Indication
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Indication
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Indication
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Indication
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Indication
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Indication
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Indication
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Indication
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Indication
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Indication
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Indication
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Indication
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. World Precision Instruments
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. AccuTec, Inc.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. Becton, Dickinson and Company
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Cardinal Health Inc.
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Innovia Medical
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Key strategic moves and developments
9.6. KAI Group
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Jai Surgicals Ltd.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Paramount Surgimed Limited
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Integra LifeSciences
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Vernacare
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
List of Tables
Table 01. Global Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 02. Skin Biopsy Market for Shave Biopsy, by Region, 2021-2031 (Revenue, $Million)
Table 03. Skin Biopsy Market for Punch Biopsy, by Region, 2021-2031 (Revenue, $Million)
Table 04. Skin Biopsy Market for Excisional Biopsy, by Region, 2021-2031 (Revenue, $Million)
Table 05. Global Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 06. Skin Biopsy Market for Skin Cancer, by Region, 2021-2031 (Revenue, $Million)
Table 07. Skin Biopsy Market for Actinic Keratosis, by Region, 2021-2031 (Revenue, $Million)
Table 08. Skin Biopsy Market for Dermatitis, by Region, 2021-2031 (Revenue, $Million)
Table 09. Skin Biopsy Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 10. Global Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 11. Skin Biopsy Market for Hospital and Clinics, by Region, 2021-2031 (Revenue, $Million)
Table 12. Skin Biopsy Market for Diagnostic Laboratories, by Region, 2021-2031 (Revenue, $Million)
Table 13. Skin Biopsy Market for Other, by Region, 2021-2031 (Revenue, $Million)
Table 14. Skin Biopsy Market, by Region, 2021-2031 (Revenue, $Million)
Table 15. North America Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 16. North America Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 17. North America Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 18. North America Skin Biopsy Market, by Country, 2021-2031 (Revenue, $Million)
Table 19. U.S. Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 20. U.S. Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 21. U.S. Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 22. Canada Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 23. Canada Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 24. Canada Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 25. Mexico Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 26. Mexico Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 27. Mexico Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 28. Europe Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 29. Europe Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 30. Europe Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 31. Europe Skin Biopsy Market, by Country, 2021-2031 (Revenue, $Million)
Table 32. Germany Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 33. Germany Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 34. Germany Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 35. France Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 36. France Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 37. France Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 38. UK Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 39. UK Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 40. UK Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 41. Italy Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 42. Italy Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 43. Italy Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 44. Spain Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 45. Spain Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 46. Spain Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 48. Rest of Europe Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 49. Rest of Europe Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 52. Asia-Pacific Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 53. Asia-Pacific Skin Biopsy Market, by Country, 2021-2031 (Revenue, $Million)
Table 54. Japan Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 55. Japan Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 56. Japan Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 57. China Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 58. China Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 59. China Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 60. India Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 61. India Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 62. India Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 63. Australia Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 64. Australia Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 65. Australia Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 66. South Korea Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 67. South Korea Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 68. South Korea Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 70. Rest of Asia-Pacific Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 71. Rest of Asia-Pacific Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 74. LAMEA Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 75. LAMEA Skin Biopsy Market, by Country, 2021-2031 (Revenue, $Million)
Table 76. Brazil Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 77. Brazil Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 78. Brazil Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 80. Saudi Arabia Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 81. Saudi Arabia Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 82. South Africa Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 83. South Africa Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 84. South Africa Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Skin Biopsy Market, by Type, 2021-2031 (Revenue, $Million)
Table 86. Rest of LAMEA Skin Biopsy Market, by Indication, 2021-2031 (Revenue, $Million)
Table 87. Rest of LAMEA Skin Biopsy Market, by End-user, 2021-2031 (Revenue, $Million)
Table 88. World Precision Instruments: Key Executives
Table 89. World Precision Instruments: Company Snapshot
Table 90. World Precision Instruments: Product Segments
Table 91. World Precision Instruments: Product Portfolio
Table 92. Accutec, Inc.: Key Executives
Table 93. Accutec, Inc.: Company Snapshot
Table 94. Accutec, Inc.: Product Segments
Table 95. Accutec, Inc.: Product Portfolio
Table 96. Becton, Dickinson and Company: Key Executives
Table 97. Becton, Dickinson and Company: Company Snapshot
Table 98. Becton, Dickinson and Company: Product Segments
Table 99. Becton, Dickinson and Company: Product Portfolio
Table 100. Cardinal Health Inc.: Key Executives
Table 101. Cardinal Health Inc.: Company Snapshot
Table 102. Cardinal Health Inc.: Product Segments
Table 103. Cardinal Health Inc.: Product Portfolio
Table 104. Cardinal Health Inc.: Key Strategies
Table 105. Innovia Medical: Key Executives
Table 106. Innovia Medical: Company Snapshot
Table 107. Innovia Medical: Product Segments
Table 108. Innovia Medical: Product Portfolio
Table 109. Innovia Medical: Key Strategies
Table 110. Kai Group: Key Executives
Table 111. Kai Group: Company Snapshot
Table 112. Kai Group: Product Segments
Table 113. Kai Group: Product Portfolio
Table 114. Jai Surgicals Ltd.: Key Executives
Table 115. Jai Surgicals Ltd.: Company Snapshot
Table 116. Jai Surgicals Ltd.: Product Segments
Table 117. Jai Surgicals Ltd.: Product Portfolio
Table 118. Paramount Surgimed Limited: Key Executives
Table 119. Paramount Surgimed Limited: Company Snapshot
Table 120. Paramount Surgimed Limited: Product Segments
Table 121. Paramount Surgimed Limited: Product Portfolio
Table 122. Integra Lifesciences: Key Executives
Table 123. Integra Lifesciences: Company Snapshot
Table 124. Integra Lifesciences: Product Segments
Table 125. Integra Lifesciences: Product Portfolio
Table 126. Vernacare: Key Executives
Table 127. Vernacare: Company Snapshot
Table 128. Vernacare: Product Segments
Table 129. Vernacare: Product Portfolio
List of Figures
Figure 01. Skin Biopsy Market, 2021-2031
Figure 02. Segmentation of Skin Biopsy Market, 2021-2031
Figure 03. Top Investment Pockets in Skin Biopsy Market (2022-2031)
Figure 04. Moderate Bargaining Power of Suppliers
Figure 05. Moderate Bargaining Power of Buyers
Figure 06. Moderate Threat of Substitutes
Figure 07. Moderate Threat of New Entrants
Figure 08. Moderate Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalskin Biopsy Market
Figure 10. Skin Biopsy Market, by Type, 2021(%)
Figure 11. Comparative Share Analysis of Skin Biopsy Market for Shave Biopsy, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Skin Biopsy Market for Punch Biopsy, by Country 2021-2031(%)
Figure 13. Comparative Share Analysis of Skin Biopsy Market for Excisional Biopsy, by Country 2021-2031(%)
Figure 14. Skin Biopsy Market, by Indication, 2021(%)
Figure 15. Comparative Share Analysis of Skin Biopsy Market for Skin Cancer, by Country 2021-2031(%)
Figure 16. Comparative Share Analysis of Skin Biopsy Market for Actinic Keratosis, by Country 2021-2031(%)
Figure 17. Comparative Share Analysis of Skin Biopsy Market for Dermatitis, by Country 2021-2031(%)
Figure 18. Comparative Share Analysis of Skin Biopsy Market for Others, by Country 2021-2031(%)
Figure 19. Skin Biopsy Market, by End-user, 2021(%)
Figure 20. Comparative Share Analysis of Skin Biopsy Market for Hospital and Clinics, by Country 2021-2031(%)
Figure 21. Comparative Share Analysis of Skin Biopsy Market for Diagnostic Laboratories, by Country 2021-2031(%)
Figure 22. Comparative Share Analysis of Skin Biopsy Market for Other, by Country 2021-2031(%)
Figure 23. Skin Biopsy Market by Region, 2021
Figure 24. U.S. Skin Biopsy Market, 2021-2031 ($Million)
Figure 25. Canada Skin Biopsy Market, 2021-2031 ($Million)
Figure 26. Mexico Skin Biopsy Market, 2021-2031 ($Million)
Figure 27. Germany Skin Biopsy Market, 2021-2031 ($Million)
Figure 28. France Skin Biopsy Market, 2021-2031 ($Million)
Figure 29. UK Skin Biopsy Market, 2021-2031 ($Million)
Figure 30. Italy Skin Biopsy Market, 2021-2031 ($Million)
Figure 31. Spain Skin Biopsy Market, 2021-2031 ($Million)
Figure 32. Rest of Europe Skin Biopsy Market, 2021-2031 ($Million)
Figure 33. Japan Skin Biopsy Market, 2021-2031 ($Million)
Figure 34. China Skin Biopsy Market, 2021-2031 ($Million)
Figure 35. India Skin Biopsy Market, 2021-2031 ($Million)
Figure 36. Australia Skin Biopsy Market, 2021-2031 ($Million)
Figure 37. South Korea Skin Biopsy Market, 2021-2031 ($Million)
Figure 38. Rest of Asia-Pacific Skin Biopsy Market, 2021-2031 ($Million)
Figure 39. Brazil Skin Biopsy Market, 2021-2031 ($Million)
Figure 40. Saudi Arabia Skin Biopsy Market, 2021-2031 ($Million)
Figure 41. South Africa Skin Biopsy Market, 2021-2031 ($Million)
Figure 42. Rest of LAMEA Skin Biopsy Market, 2021-2031 ($Million)
Figure 43. Top Winning Strategies, by Year
Figure 44. Top Winning Strategies, by Development
Figure 45. Top Winning Strategies, by Company
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Skin Biopsy Market
Figure 49. Top Player Positioning, 2021
Figure 50. Becton, Dickinson and Company: Net Revenue, 2019-2021 ($Million)
Figure 51. Becton, Dickinson and Company: Revenue Share by Segment, 2021 (%)
Figure 52. Becton, Dickinson and Company: Revenue Share by Region, 2021 (%)
Figure 53. Cardinal Health Inc.: Net Revenue, 2020-2022 ($Million)
Figure 54. Cardinal Health Inc.: Revenue Share by Segment, 2022 (%)
Figure 55. Cardinal Health Inc.: Revenue Share by Region, 2022 (%)
Figure 56. Integra Lifesciences: Net Revenue, 2019-2021 ($Million)
Figure 57. Integra Lifesciences: Revenue Share by Segment, 2021 (%)
Figure 58. Integra Lifesciences: Revenue Share by Region, 2021 (%)
Executive Summary
According to the report titled, 'Skin Biopsy Market,' the skin biopsy market was valued at $101.20 million in 2021, and is estimated to reach $181.6 million by 2031, growing at a CAGR of 6% from 2022 to 2031.The skin biopsy market is likely to experience a significant growth rate of 6.0% from 2022-2031 owing to increasing market demand from diagnostic & biotech sector.
Skin biopsy is referred to a diagnostic technique which involves removal of small skin sample and further examining it under the microscope to detect the skin condition. It has a wide application in detection of skin cancer caused due to various factors including UV light exposure and use of harmful cosmetics. The sample is collected using techniques such as shave biopsy, punch biopsy and others. This sample is then examined and thus help the dermatologist to detect the severity of the skin condition. Moreover, skin biopsy is used for research purposes in the field of dermatology, and treatment planning for cosmetic procedures.
Key factors driving the growth of the skin biopsy market include rise in prevalence of skin cancer and rise in adoption of minimally invasive procedures. In addition, increase in expenditure on instruments and medical devices by the hospitals and diagnostic centers is driving the growth of the market. There is a rise in adoption of advanced tools and techniques by the healthcare provider for diagnosis and treatment of severe conditions such as skin cancer, which leads to the rise in adoption of new skin biopsy instruments. Thus, driving the growth of the skin biopsy market.
Furthermore, the market is expanding as a result of an increase in cancer-related R&D activities. In the recent years, there has been an increase in skin cancer research activities as a result of an increase in skin cancer cases, which further assists in the development of cutting-edge diagnostic and therapeutic methods. Thus, since there are more research projects ongoing, there is also a greater need for skin biopsies to collect samples from a large number of patients, which in turn fuels the market for skin biopsy.
Increase in awareness among the people in developing regions regarding new diagnosis and treatment technologies such as skin biopsy is anticipated to drive the market in the forecast period. The government agencies are collaborating with medical devices manufacturers for creating awareness among the population regarding skin biopsy as a diagnostic technique for sin cancer. Also, initiatives are taken by the organizations in healthcare field to create awareness about early diagnosis of skin cancer and skin conditions that may lead to severe melanoma. This, offers opportunities for the key market players to invest and manufacture skin biopsy products, which is anticipated to drive the market during the forecast period.
Moreover, emerging markets in the Asia-Pacific region and LAMEA provide market participants great potentials. During the forecast period, it is anticipated that rising healthcare spending, industrial growth, and investments from developed nations in the Asia-Pacific region, as well as rapidly increasing knowledge of new techniques and technologies for diagnosing and treating various skin conditions, all will have a positive impact on the market.
The global skin biopsy market is segmented into type, indication, end user and region. By type, the market is categorized into shave biopsy, punch biopsy, and excisional biopsy. On the basis of indication, the market is segregated into skin cancer, actinic keratosis, dermatitis and others. On the basis of end user, the market is categorized into hospitals and clinics, diagnostic laboratories and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include AccuTec, Inc., Becton, Dickinson and Company, Cardinal Health, Innovia Medical (DTR Medical Ltd), Integra LifeSciences, Jai Surgicals Ltd., Kai Group, Paramount Surgimed Ltd., Verna care and World Precision Instruments (WPI). The players in the market have been actively engaged in the adoption various Strategies such as acquisition, branding and expansion to remain competitive and gain advantage over the competitors in the market. For instance, in October 2019, Innovia Medical announced the acquisition of DTR Medical which is based in Swansea, Wales, UK. DTR Medical specializes in the design and manufacture of Single-use surgical instruments for general and specialist surgical procedures.
Key Market Insights
- By type, the punch biopsy segment was the highest revenue contributor to the market and is estimated to reach $146.56 million by 2031, with a CAGR of 6.2%. It is also estimated to be the fastest-growing segment during the forecast period.
- By indication, the skin cancer segment dominated the global market and is expected to be the fastest-growing segment with a CAGR of 6.4% during the forecast period.
- Based on end user, the hospital and clinics segment was the highest revenue contributor to the market with a CAGR of 6.5% during the forecast period. On the other hand, diagnostic laboratories segment is anticipated to grow at the fastest rate during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest rate during the forecast period.
Companies Mentioned
- AccuTec, Inc.
- Cardinal Health Inc.
- Innovia Medical
- Jai Surgicals Ltd.
- Integra LifeSciences
- Vernacare
- Becton, Dickinson and Company
- KAI Group
- Paramount Surgimed Limited
- World Precision Instruments
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
